Document is current
Any future updates will be listed below
-
Authors
Lofredi, Roxanne https://orcid.org/0000-0002-1845-8250
Feldmann, Lucia K. https://orcid.org/0000-0003-1290-208X
Krause, Patricia
Scheller, Ute https://orcid.org/0000-0003-4202-2470
Neumann, Wolf-Julian https://orcid.org/0000-0002-6758-9708
Krauss, Joachim K. https://orcid.org/0000-0002-0675-9064
Saryyeva, Assel
Schneider, Gerd-Helge
Faust, Katharina
Sander, Tilmann https://orcid.org/0000-0003-2984-5579
Kühn, Andrea A. https://orcid.org/0000-0002-4134-9060
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC-2049 – 390688087)
- License Information
-
More Information
Article History
Received: 18 September 2023
Accepted: 23 September 2024
First Online: 1 October 2024
Competing interests
: Dr. Lofredi, Dr. Feldmann and Prof. Neumann report personal fees from Medtronic. Prof. Kühn reports personal fees from Medtronic, and Boston Scientific. Dr. Krause reports personal fees from Medtronic, Stadapharm and Abbvie. Prof. Krauss reports personal fees from Medtronic, personal fees from Boston Scientific. Dr. Schneider reports personal fees from Medtronic, personal fees from Boston Scientific, personal fees from Abbott. All personal fees are not linked to the here presented study results. The remaining authors declare no competing interests.
